Synthesis of cyclic sulfonamides via intramolecular copper-catalyzed reaction of unsaturated iminoiodinanes

Organic Letters

Volumn 2, Issue 15, 2000, Pages 2327-2329

  Dauban, Philippe ^a   Dodd, Robert H ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOAZOBENZENE; AZIRIDINE DERIVATIVE; COPPER; DRUG DERIVATIVE; ENZYME INHIBITOR; FUSED HETEROCYCLIC RINGS; SULFAMIDOCHRYSOIDINE; SULFONAMIDE;

ARTICLE; CATALYSIS; CHEMISTRY; METABOLISM; SYNTHESIS;

AZIRIDINES; CATALYSIS; COPPER; ENZYME INHIBITORS; HETEROCYCLIC COMPOUNDS, 2-RING; P-AMINOAZOBENZENE; SULFONAMIDES;

EID: 0034720908     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol000130c     Document Type: Article

References (39)

1. Domagk, G. Dtsch. Med. Wochenschr. 1935, 61, 250.
2. For a review, see: (a) Hansch, C.; Sammes, P. G.; Taylor, J. B. Comprehensive Medicinal Chemistry; Pergamon Press: Oxford, 1990; Vol. 2, Chapter 7.1.
3. For a compilatory list of recent biological applications, see (b) Hanson, P. R.; Probst, D. A.; Robinson, R. E.; Yau, M. Tetrahedron Lett. 1999, 40, 4761.
4. de Bont, D. B. A.; Sliedregt-Bol, K. M.; Hofmeyer, L. J. F.; Liskamp, R. M. J. Bioorg. Med. Chem. 1999, 7, 1043.
5. Drugs Future 1992, 17, 451.
6. (a) Drugs Future 1997, 22, 341.
7. (b) Drugs Future 1986, 11, 565.
8. (a) Combrink, K. D.; Gulgeze, H. B.; Meanwell, N. A.; Pearce, B. C.; Zulan, P.; Bisacchi G. S.; Roberts, D. G.; Stanley, P.; Seiler, S. M. J. Med. Chem. 1998, 41, 4854.
9. (b) Hlasta, D. J.; Subramanyam, C.; Bell, M. R.; Carabateas, P. M.; Court, J. J.; Desai, R. C.; Drozd, M. L.; Eickhoff, W. M.; Ferguson, E. W.; Gordon, R. J.; Johnson, J. A.; Kumar, V.; Maycock, A. L.; Mueller, K. R.; Pagani, E. D.; Robinson, D. T.; Saindane, M. T.; Silver, P. J.; Subramanian, S. J. Med. Chem. 1995, 38, 739.
10. Tanimukai, H.; Inoui, M.; Hariguchi, S.; Kaneko, Z. Biochem. Pharmacol. 1965, 14, 961.
11. (a) Drugs Future 1998, 23, 365.
12. (b) Silver, L. H. Am. J. Ophthalmol. 1998, 126, 400.
13. (a) Becking, J. B.; Sprague, J. M. U.S. Patent 3,113,075, 1963; Chem. Abstr. 1964, 60, 5514g.
14. (b) Sianesi, E.; Da Re, P.; Setnikar, I.; Massarani, E. U.S. Patent 3,770,733, 1973; Chem. Abstr. 1974, 80, 48016p.
15. (c) Tamada, S.; Fujioka, T.; Ogawa, H.; Teramoto, S.; Kondo, K. Chem. Abstr. 1990, 112, 35887e.
16. (d) Chem. Abstr. 1985, 102, 78901p.
17. (e) Pasteris, R. J. U.S. Patent 4,842,639, 1989; Chem. Abstr. 1990, 112, 179032t.
18. Oppolzer, W. Pure Appl. Chem. 1990, 62, 1241.
19. (a) Davis, F. A.; Chen, B.-C. Chem. Rev. 1992, 92, 919.
20. (b) Differding, E.; Lang, R. Helv. Chim. Acta 1989, 72, 1248.
21. (a) The Chemistry of Sulphonic Acids, Esters and Derivatives; Patai, S.; Rappoport, Z., Eds.; Wiley Interscience: New York, 1991; Chapter 19.
22. (b) Katritzky, A. R.; Wu, J.; Rachwal, B.; Macomber, D. W.; Smith, T. P. Org. Prep. Proc. Int. 1992, 24, 463.
23. (a) Bonfand, E.; Motherwell, W. B.; Pennell, A. M. K.; Uddin, M. K.; Ujjainwalla, F. Heterocycles 1997, 46, 523.
24. (b) Paquette, L. A.; Leit, S. M. J. Am. Chem. Soc. 1999, 121, 8126.
25. (c) Leit, S. M.; Paquette, L. A. J. Org. Chem. 1999, 64, 9225.
26. (d) Katohgi, M.; Togo, H.; Yamaguchi, K.; Yokoyama, M. Tetrahedron 1999, 55, 14885.
27. (e) Togo, H.; Harada, Y.; Yokohama, M. J. Org. Chem. 2000, 65, 926.
28. Dauban, P.; Dodd, R. H. J. Org. Chem. 1999, 64, 5304.
29. Evans, D. A.; Faul, M. M.; Bilodeau, M. T. J. Am. Chem. Soc. 1994, 116, 2742.
30. Boucher, M.; Macikenas, D.; Ren, T.; Protasiewicz, J. D. J. Am. Chem. Soc. 1997, 119, 9366.
31. (a) King, J. F.; Harding, D. R. K. J. Am. Chem. Soc. 1976, 98, 3312.
32. (b) Culshaw, P. N.; Walton, J. C. J. Chem. Soc., Perkin Trans. 2, 1991, 1201.
33. Lombardino, J. G. J. Org. Chem. 1971, 36, 1843.
34. Wang, Q.; Wei, H.-X.; Schlosser, M. Eur. J. Org. Chem. 1999, 3263
35. 1H NMR spectra in which aromatic protons of the iodobenzene moiety were observed together with the disappearance of those of the sulfonamide function and the upfield shift of the alkane protons. For example, for the iminoiodinane derived from sulfonamide 9c: δ 1.26 (m, 2H), 1.76 (m, 2H), 2.00 (m, 2H), 4.95 (m, 2H), 5.64 (m, 1H), 7.39 (m, 2H), 7.54 (m, 1H), 7.96 (d, 1H).
36. The iodinanes were used as soon as they were isolated in order to optimize the yield of the aziridination. However, they could be stored at 4 °C under argon for several days. Their stability is therefore comparable to that of PhINTs or PhINSes.
37. To the best of our knowledge, there is only one example of the preparative use of such a Cu-catalyzed C-H insertion: Overman, L. E.; Tomasi, A. L. J. Am. Chem. Soc. 1998, 120, 4039. In other cases, such compounds were isolated as minor byproducts. For example, see: (a) ref 15. (b) Albone, D. P.; Aujla, P. S.; Taylor, P. C.; Challenger, S., Derrick, A. M. J. Org. Chem. 1998, 63, 9569.
38. To the best of our knowledge, there is only one example of the preparative use of such a Cu-catalyzed C-H insertion: Overman, L. E.; Tomasi, A. L. J. Am. Chem. Soc. 1998, 120, 4039. In other cases, such compounds were isolated as minor byproducts. For example, see: (a) ref 15. (b) Albone, D. P.; Aujla, P. S.; Taylor, P. C.; Challenger, S., Derrick, A. M. J. Org. Chem. 1998, 63, 9569.
39. Jeong, J. U.; Tao, B.; Sagasser, I.; Henniges, H.; Sharpless, K. B. J. Am. Chem. Soc. 1998, 120, 6844.